H. Oya Alpar

4.8k total citations · 1 hit paper
103 papers, 3.8k citations indexed

About

H. Oya Alpar is a scholar working on Molecular Biology, Pharmaceutical Science and Immunology. According to data from OpenAlex, H. Oya Alpar has authored 103 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 41 papers in Pharmaceutical Science and 30 papers in Immunology. Recurrent topics in H. Oya Alpar's work include Advanced Drug Delivery Systems (36 papers), RNA Interference and Gene Delivery (29 papers) and Immunotherapy and Immune Responses (20 papers). H. Oya Alpar is often cited by papers focused on Advanced Drug Delivery Systems (36 papers), RNA Interference and Gene Delivery (29 papers) and Immunotherapy and Immune Responses (20 papers). H. Oya Alpar collaborates with scholars based in United Kingdom, Türkiye and United States. H. Oya Alpar's co-authors include Haliza Katas, Jim Eyles, Vincent W. Bramwell, António J. Almeida, Satyanarayana Somavarapu, E. Diane Williamson, E. Diane Williamson, Kwame N. Atuah, Ian D. Spiers and David Lewis and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

H. Oya Alpar

103 papers receiving 3.7k citations

Hit Papers

Development and characterisation of chitosan nanoparticle... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Oya Alpar United Kingdom 34 1.6k 1.5k 843 578 408 103 3.8k
Thomas R. Tice United States 22 890 0.5× 1.2k 0.8× 599 0.7× 625 1.1× 329 0.8× 39 3.0k
Sarah Hook New Zealand 35 1.5k 0.9× 1.0k 0.7× 950 1.1× 529 0.9× 211 0.5× 116 3.5k
Carlos Gamazo Spain 40 1.7k 1.0× 975 0.7× 908 1.1× 603 1.0× 470 1.2× 132 5.2k
Pål Johansen Switzerland 39 1.3k 0.8× 821 0.6× 1.8k 2.2× 316 0.5× 386 0.9× 115 4.9k
Richard M. Gilley United States 20 863 0.5× 1.0k 0.7× 809 1.0× 382 0.7× 453 1.1× 31 2.8k
Camilla Foged Denmark 44 3.4k 2.1× 1.2k 0.8× 1.9k 2.2× 908 1.6× 704 1.7× 129 6.3k
Gideon Kersten Netherlands 44 2.6k 1.6× 1.7k 1.1× 1.8k 2.2× 342 0.6× 1.1k 2.6× 125 6.3k
Michael J. Wannemuehler United States 43 1.9k 1.2× 512 0.3× 2.0k 2.3× 464 0.8× 939 2.3× 177 5.4k
Jay K. Staas United States 16 699 0.4× 830 0.6× 726 0.9× 222 0.4× 436 1.1× 20 2.2k
Bram Slütter Netherlands 35 1.6k 1.0× 976 0.7× 2.1k 2.4× 311 0.5× 348 0.9× 81 3.7k

Countries citing papers authored by H. Oya Alpar

Since Specialization
Citations

This map shows the geographic impact of H. Oya Alpar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Oya Alpar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Oya Alpar more than expected).

Fields of papers citing papers by H. Oya Alpar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Oya Alpar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Oya Alpar. The network helps show where H. Oya Alpar may publish in the future.

Co-authorship network of co-authors of H. Oya Alpar

This figure shows the co-authorship network connecting the top 25 collaborators of H. Oya Alpar. A scholar is included among the top collaborators of H. Oya Alpar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Oya Alpar. H. Oya Alpar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alpar, H. Oya, et al.. (2009). An investigation into the combination of low frequency ultrasound and liposomes on skin permeability. International Journal of Pharmaceutics. 379(1). 139–142. 21 indexed citations
2.
Alpar, H. Oya, et al.. (2008). Transcutaneous immunisation assisted by low-frequency ultrasound. International Journal of Pharmaceutics. 368(1-2). 123–128. 35 indexed citations
4.
Singh, J. B., et al.. (2006). Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods. 38(2). 96–105. 82 indexed citations
5.
Elvin, Stephen J., et al.. (2005). Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. Vaccine. 24(20). 4433–4439. 25 indexed citations
6.
Alpar, H. Oya. (2003). Strategies for Vaccine Delivery. Journal of drug targeting. 11(8-10). 459–461. 4 indexed citations
7.
Atuah, Kwame N., E. Walter, Hans P. Merkle, & H. Oya Alpar. (2003). Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: A comparison of solvent evaporation and spray-drying methods. Journal of Microencapsulation. 20(3). 387–399. 17 indexed citations
8.
Alpar, H. Oya & Vincent W. Bramwell. (2002). Current Status of DNA Vaccines and Their Route of Administration;. Critical Reviews in Therapeutic Drug Carrier Systems. 19(4-5). 307–384. 24 indexed citations
9.
Alpar, H. Oya, et al.. (2001). Intranasal vaccination against plague, tetanus and diphtheria. Advanced Drug Delivery Reviews. 51(1-3). 173–201. 79 indexed citations
11.
Eyles, Jim, E. Diane Williamson, Ian D. Spiers, et al.. (2000). Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. Journal of Controlled Release. 63(1-2). 191–200. 30 indexed citations
12.
Eyles, Jim, E. Diane Williamson, & H. Oya Alpar. (1999). Immunological responses to nasal delivery of free and encapsulated tetanus toxoid: studies on the effect of vehicle volume. International Journal of Pharmaceutics. 189(1). 75–79. 47 indexed citations
13.
Conway, Barbara R. & H. Oya Alpar. (1997). Single and Coencapsulation of lnterferon-γ in Biodegradable PLA Microspheres for Optimization of Multicomponent Vaccine Delivery Vehicles. Drug Delivery. 4(2). 75–80. 3 indexed citations
14.
Alpar, H. Oya, et al.. (1997). Potential of particulate carriers for the mucosal delivery of DNA vaccines. Biochemical Society Transactions. 25(2). 337S–337S. 9 indexed citations
15.
Conway, Barbara R. & H. Oya Alpar. (1996). Double emulsion microencapsulation of proteins as model antigens using polylactide polymers : effect of emulsifier on the microsphere characteristics and release kinetics. European Journal of Pharmaceutics and Biopharmaceutics. 42(1). 42–48. 35 indexed citations
16.
Conway, Barbara R. & H. Oya Alpar. (1996). Co-encapsulation of proteins into PLA microspheres. University of Huddersfield Repository (University of Huddersfield). 2 indexed citations
17.
Conway, Barbara R. & H. Oya Alpar. (1996). Co‐encapsulation of Proteins into Polylactide Microspheres. Pharmacy and Pharmacology Communications. 2(4). 173–176. 3 indexed citations
18.
Almeida, António J. & H. Oya Alpar. (1996). Nasal Delivery of Vaccines. Journal of drug targeting. 3(6). 455–467. 95 indexed citations
19.
Alpar, H. Oya, et al.. (1994). Preparation, properties and the effects of free and liposomal tobramycin on siderophore production by Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 34(1). 43–52. 8 indexed citations
20.
Almeida, António J., H. Oya Alpar, & Michael R. Brown. (1993). Immune Response to Nasal Delivery of Antigenically Intact Tetanus Toxoid Associated with Poly(l-lactic acid) Microspheres in Rats, Rabbits and Guinea-pigs. Journal of Pharmacy and Pharmacology. 45(3). 198–203. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026